HealthEquity (NASDAQ:HQY) EVP Sells $138,105.00 in Stock

Key Points

• HealthEquity EVP Delano Ladd sold 1,500 shares for a total of $138,105, reducing his stake by 1.91% to 76,979 shares.
• The company's stock is currently priced at $95.48, down 0.5%, with a market capitalization of $8.23 billion.
• HealthEquity reported earnings of $0.92 per share for its last quarter, meeting analysts' estimates, with projected FY 2026 EPS guidance set at 3.740-3.91.

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) EVP Delano Ladd sold 1,500 shares of the stock in a transaction that occurred on Monday, October 20th. The stock was sold at an average price of $92.07, for a total transaction of $138,105.00. Following the transaction, the executive vice president directly owned 76,979 shares of the company's stock, valued at $7,087,456.53. The trade was a 1.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Delano Ladd also recently made the following trade(s):

• On Friday, September 19th, Delano Ladd sold 6,000 shares of HealthEquity stock. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00.

HealthEquity Stock Down 0.5%

HQY stock traded down $0.52 during midday trading on Wednesday, hitting $95.48. The company's stock had a trading volume of 1,044,480 shares, compared to its average volume of 1,020,239. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 52-week low of $74.07 and a 52-week high of $116.65. The firm has a market capitalization of $8.23 billion, a P/E ratio of 57.87, a PEG ratio of 1.34 and a beta of 0.47. The firm has a 50-day simple moving average of $91.77 and a 200-day simple moving average of $94.21.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. The business had revenue of $325.80 million for the quarter, compared to analyst estimates of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. As a group, equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Hedge Funds Weigh In On HealthEquity

Institutional investors have recently modified their holdings of the company. Nisa Investment Advisors LLC increased its position in HealthEquity by 2.9% during the second quarter. Nisa Investment Advisors LLC now owns 3,787 shares of the company's stock worth $397,000 after purchasing an additional 108 shares during the last quarter. Advisors Asset Management Inc. increased its position in HealthEquity by 4.7% during the second quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company's stock worth $255,000 after purchasing an additional 110 shares during the last quarter. Ieq Capital LLC increased its position in HealthEquity by 4.4% during the first quarter. Ieq Capital LLC now owns 2,945 shares of the company's stock worth $260,000 after purchasing an additional 123 shares during the last quarter. Xponance Inc. increased its position in HealthEquity by 1.1% during the first quarter. Xponance Inc. now owns 12,412 shares of the company's stock worth $1,097,000 after purchasing an additional 136 shares during the last quarter. Finally, Coldstream Capital Management Inc. increased its position in HealthEquity by 7.3% during the second quarter. Coldstream Capital Management Inc. now owns 2,027 shares of the company's stock worth $212,000 after purchasing an additional 138 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Jefferies Financial Group raised their price objective on shares of HealthEquity from $130.00 to $134.00 and gave the company a "buy" rating in a report on Wednesday, September 3rd. Royal Bank Of Canada upped their price objective on shares of HealthEquity from $109.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, September 3rd. Barrington Research restated an "outperform" rating and issued a $125.00 price objective on shares of HealthEquity in a research note on Friday, August 29th. KeyCorp dropped their price target on shares of HealthEquity from $125.00 to $120.00 and set an "overweight" rating on the stock in a research note on Wednesday, October 8th. Finally, Weiss Ratings reiterated a "hold (c+)" rating on shares of HealthEquity in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $121.31.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.